Scientists suggest understanding ecDNA’s role in pancreatic cancer could potentially guide future strategies for making ...

Researchers have discovered race-associated molecular differences in tumors that may impact the way patients with pancreatic ...

Pancreatic cancer is one of the deadliest cancers worldwide, with a five-year survival rate of 13%. This poor prognosis stems from both late detection and the cancer’s notorious capacity to adapt and ...

Understanding your tumor biology is key to finding the right treatment for pancreatic cancer. Identifying mutations, or changes in a [...] READ MORE ...

Scientists at Memorial Sloan Kettering Cancer Center have developed personalized mRNA vaccines for pancreatic cancer, with ...

Patients with pancreatic cancer who participate in clinical research have better outcomes. PanCAN strongly recommends clinical trials at diagnosis and during every treatment decision. Clinical trials ...

The biotech company Dynamic42, a specialist in organ-on-chip technology, has made a significant advance in pancreatic cancer ...

The microbiome shapes development of insulin-producing cells in infancy, leading to long-term changes in metabolism and diabetes risk, new research in mice has found.

The results could ultimately help doctors reduce the risk of type 1 diabetes—or potentially even restore lost metabolic function in adulthood—by providing gut microbes that help the pancreas grow and ...

The microbiome shapes the development of insulin-producing cells in infancy, leading to long-term changes in metabolism and ...

A team of German scientists and biotech company Dynamic42 have jointly developed a ‘tumour-on-chip’ model of pancreatic ...